When It Comes To Shampoo, Less Is More

Private collection.

“Americans love to shampoo. We lather up an average of 4.59 times a week, twice as much as Italians and Spaniards, according to shampoo-maker Procter & Gamble.

But that’s way too often, say hair stylists and dermatologists. Daily washing, they say, strips the hair of beneficial oil (called sebum) and can damage our locks.” via NPR.

No Legal Shield in Drug Labeling, Justices Rule

:Original raster version: :en::Image:Food and ...

Very disappointing to Big Pharma, which of course only accepts greater regulation in hopes it will protect it.

“The court, by a 6-to-3 vote, upheld a jury verdict of $6.7 million in favor of a musician from Vermont whose arm had to be amputated after she was injected with an antinausea drug. The drug’s manufacturer, Wyeth, had argued that its compliance with the Food and Drug Administration’s labeling requirements should immunize it from lawsuits.” via NYTimes.com.

Related:

GlaxoSmithKline pledges cheap medicine for world’s poor

GlaxoSmithKline

Good news, if the cynic in me could only come to believe it:

‘The world’s second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.

In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents.

Witty says he believes drug companies have an obligation to help the poor get treatment. He challenges other pharmaceutical giants to follow his lead.

Pressure on the industry has been growing over the past decade, triggered by the Aids catastrophe…’

via The Guardian.